Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Researchers hope to combine gene editing with a less toxic stem cell transplant. Findings may apply to cancer and other illnesses.
An experimental approach to protect HIV-fighting T cells has been cleared for its first human trial.
Edited T cells survive and thrive in three patients in the first U.S. trial using this approach.
Researchers have developed a new gene therapy approach for children with severe combined immunodeficiency.
The animals have 100 times as many cells as humans but rarely get cancer. New gene studies may help explain why.
For example: Hep C cures have meant fewer people to treat and fewer transmissions to potential patients.
The short answer is yes. but the procedure isn’t suitable for everyone.
Sickle-cell anemia remains more common among people of African ancestry, but science has made strides in treating this blood-borne disease.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.